Incidence of diabetes following ramipril or rosiglitazone withdrawal

OBJECTIVE - To examine the impact of withdrawing rosiglitazone and ramipril medication on diabetes incidence after closeout of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. RESEARCH DESIGN AND METHODS - The 3,366 DREAM subjects at trial end who had not d...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Holman, R, Zinman, B, Yusuf, S, Sheridan, P, Anand, S, Bosch, J, Conget, I, Davies, M, Pirags, V, Dagenais, G, Pogue, J, Zimmet, P, Gerstein, H
Formatua: Journal article
Hizkuntza:English
Argitaratua: 2011